Assessing Cardiovascular Risk in Patients with Diabetes: An Update

被引:42
作者
Damaskos, Christos [1 ]
Garmpis, Nikolaos [1 ]
Kollia, Paraskevi [2 ]
Mitsiopoulos, Georgios [3 ]
Barlampa, Danai [4 ]
Drosos, Athanasios [5 ]
Patsouras, Alexandros [1 ]
Gravvanis, Nikolaos [6 ]
Antoniou, Vasileios [7 ]
Litos, Alexandros [8 ]
Diamantis, Evangelos [9 ]
机构
[1] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Med Sch, Dept Propedeut Surg 2, Athens, Greece
[2] Univ Athens, Hippokrat Hosp Athens, Dept Otorhinolaryngol 1, Athens, Greece
[3] Hlth Ctr Acharnes, Athens, Greece
[4] Pamakaristos Hosp, Dept Internal Med, Athens, Greece
[5] KAT Gen Hosp, Dept Internal Med, Athens, Greece
[6] Hlth Ctr Peristeriou, Athens, Greece
[7] St Savvas Anticanc Hosp, Breast Surg Clin, Athens, Greece
[8] Dromokaiteio Psychiat Hosp, Athens 12461, Greece
[9] G Gennimatas Gen Hosp Athens, Dept Endocrinol & Diabet Ctr, Athens, Greece
关键词
Diabetes; cardiovascular risk; risk assessment; biomarkers; low density lipoprotein; coronary heart disease; EXCESS RISK; DISEASE; MORTALITY; METAANALYSIS; EVENTS; SCORE; GUIDELINES; MELLITUS; OUTCOMES; SMOKING;
D O I
10.2174/1573403X15666191111123622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The globalization of the Western lifestyle has resulted in increase of diabetes mellitus, a complex, multifactorial disease. Diabetes mellitus is a condition often related to the disorders of the cardiovascular system. It is well established that three quarters of diabetics, aged over 40, will die from cardiovascular disease and are more likely than non-diabetics to die from their first cardiovascular event. Therefore, it is of paramount importance to individualize treatment via risk stratification. Conditions that increase cardiovascular risk in people with diabetes include age more than 40 years, male gender, history of relative suffering from premature CHD, blood pressure and high LDL levels, presence of microalbuminuria, obstructive sleepapnea, erectile dysfunction and other conditions. Several models have been developed in order to assess cardiovascular risk in people with and without diabetes. Some of them have been proven to be inadequate while others are widely used for years. An emerging way of risk assessment in patients with diabetes mellitus is the use of biomarkers but a lot of research needs to be done in this field in order to have solid conclusions.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 50 条
  • [31] Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes
    Croyal, Mikael
    Saulnier, Pierre-Jean
    Aguesse, Audrey
    Gand, Elise
    Ragot, Stephanie
    Roussel, Ronan
    Halimi, Jean-Michel
    Ducrocq, Gregory
    Cariou, Bertrand
    Montaigne, David
    Wargny, Matthieu
    Krempf, Michel
    Hadjadj, Samy
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (07) : 2371 - 2380
  • [32] Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: A real-world national cohort analysis
    Salem, Ahmed M.
    Harris, Daniel
    Obaid, Daniel R.
    Stephens, Jeffrey W.
    Halcox, Julian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 377 : 104 - 111
  • [33] Comparison of cardiovascular risk calculators in patients with diabetes
    Ribeiro, Luana Karem
    Amorim, Welma Wildes
    Alvin Cardoso, Igor Thiago
    Vieira, Wester Silva
    Kochergin, Clavdia Nicolaevna
    de Medeiros, Danielle Souto
    Soares, Daniela Arruda
    Louzado, Jose Andrade
    Silva, Kelle Oliveira
    Cortes, Matheus Lopes
    Mistro, Sostenes
    Bezerra, Vanessa Moraes
    Oliveira, Marcio Galvao
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (02): : 200 - 206
  • [34] Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study
    Ceriello, Antonio
    Lucisano, Giuseppe
    Prattichizzo, Francesco
    Grotta, Rosalba La
    Franzen, Stefan
    Gudbjornsdottir, Soffia
    Eliasson, Bjorn
    Nicolucci, Antonio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (08) : 719 - 727
  • [35] Economic burden and risk of cardiovascular disease and diabetes in patients with different cardiometabolic risk profiles
    Caro, J. Jaime
    O'Brien, Judith A.
    Hollenbeak, Christopher S.
    Spackman, Eldon
    Ben-Joseph, Rami
    Okamoto, Lynn J.
    Paramore, L. Clark
    VALUE IN HEALTH, 2007, 10 : S12 - S20
  • [36] Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
    Katsiki, Niki
    Kotsa, Kalliopi
    Stoian, Anca P.
    Mikhailidis, Dimitri P.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (43) : 5637 - 5649
  • [37] Risk for cardiovascular events in an Italian population of patients with type 2 diabetes
    Pellegrini, E.
    Maurantonio, M.
    Giannico, I. M.
    Simonini, M. S.
    Ganazzi, D.
    Carulli, L.
    D'Amico, R.
    Baldini, A.
    Loria, P.
    Bertolotti, M.
    Carulli, N.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (11) : 885 - 892
  • [38] Sleep Apnea and Cardiovascular Risk in Patients with Prediabetes and Type 2 Diabetes
    Paschou, Stavroula A.
    Bletsa, Evanthia
    Saltiki, Katerina
    Kazakou, Paraskevi
    Kantreva, Kanella
    Katsaounou, Paraskevi
    Rovina, Nikoletta
    Trakada, Georgia
    Bakakos, Petros
    Vlachopoulos, Charalambos V.
    Psaltopoulou, Theodora
    NUTRIENTS, 2022, 14 (23)
  • [39] Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus
    Evans, Marc
    Kozlovski, Plamen
    Paldanius, Paivi M.
    Foley, James E.
    Bhosekar, Vaishali
    Serban, Carmen
    Avogaro, Angelo
    DIABETES THERAPY, 2018, 9 (01) : 27 - 36
  • [40] Inflammatory risk of albumin combined with C-reactive protein predicts long-term cardiovascular risk in patients with diabetes
    Xu, Xiaoqun
    Zhu, Houyong
    Wang, Hanxin
    Zhu, Xinyu
    Liu, Libin
    Zhang, Fengwei
    Zhou, Hongjuan
    Zhu, Mingzhi
    Dai, Lingshan
    Cai, Long
    AGING-US, 2024, 16 (07): : 6348 - 6363